Published June 2010 | Version v1
Journal article

Diagnostic value of combined measurement of serum CEA, AFP, CA19-9 and SA levels in patients with primary hepatic cancer

Creators

  • 1. Department of Laboratory, Lianyungang Second Municipal People's Hospital, Lianyungang (China)

Description

Objective: To study the diagnostic value of combined measurement of serum CEA, AFP, CA19-9 and SA levels for primary hepatic cancer. Methods: Serum CEA, AFP, CA19-9 (with RIA) SA (with biochemistry) levels were measured in 36 patients with primary hepatic cancer and 35 controls. Results: As a single tumor marker for diagnosis, the sensitivity of CEA, AFP, CA19-9, SA was 33.3%, 69.4%, 58.5% and 61.1% respectively, the specificity was 60.4%, 81.3% 68.8%, 64.4% respectively. With combined detection of the four markers and assuming two or more markers positive as positive, the sensitivity would be 94.4% and specificity would be 95.8%. Conclusion: Combined measurement of serum CEA, AFP, CA19-9 and SA levels is of clinical usefulness for diagnosis of primary hepatic cancer. (authors)

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
23
Journal Issue
3
Journal Page Range
p. 266-267
ISSN
1008-9810

Optional Information

Notes
3 tabs., 8 refs.